Fluorine-18 deoxyglucose Positron Emission Tomography, Magnetic Resonance Imaging and Bone Scintigraphy for the Diagnosis of Bone Metastases in Patients with Lung Cancer: Which One is the Best? – a Meta-analysis
Authors:
- 30 June 2011
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 23 (5) , 350-358
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The Role of Whole-Body FDG PET/CT, Tc 99m MDP Bone Scintigraphy, and Serum Alkaline Phosphatase in Detecting Bone Metastasis in Patients with Newly Diagnosed Lung CancerJournal of Korean Medical Science, 2009
- Skeletal metastases in non-small cell lung cancer: A retrospective studyLung Cancer, 2007
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancerLung Cancer, 2004
- Current surgical treatment of nonsmall cell lung cancer 2001European Respiratory Journal, 2002
- Advanced methods in meta‐analysis: multivariate approach and meta‐regressionStatistics in Medicine, 2002
- Is There a “Best” Way to Detect and Minimize Publication Bias?Evaluation & the Health Professions, 2001
- Bone metastases—The clinical problemEuropean Journal of Cancer, 1998
- Regression Analysis for Correlated DataAnnual Review of Public Health, 1993
- Limitations of bone scanning in clinical oncology1975